Updates in Pharmacotherapy for Smoking Cessation

Journal for Nurse Practitioners

Volumn 12, Issue 6, 2016, Pages 421-422

  Mospan, Cortney ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84962295017     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2016.02.022     Document Type: Article

References (5)

1. Clinical Guidelines for Prescribing Pharmacotherapy for Smoking Cessation 2012, Agency for Healthcare Research and Quality, AHRQ, Rockville, Md.
2. Kalkhoran S., Glantz S.A. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016, 4(2):116-128.
3. US Food and Drug Administration. Nicotine replacement therapy labels may change. April 1, 2013. Accessed February 9, 2016. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm345087.htm/.
4. Anthenelli R.M., Morris C., Ramey T.S., et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med 2013, 159:390-400.
5. Chelladuarai Y., Singh S. Varenicline and cardiovascular adverse events: a perspective review. Ther Adv Drug Saf 2014, 5(4):167-172.